The Lancet Oncology
Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.
Junck L., Heth J., Hollon T., Kim M.M., Wahl D.R., Camelo-Piragua S., Venneti S., Zhao L., Murasko K., Castro M.G., Lowenstein P.